scholarly article | Q13442814 |
P2093 | author name string | Nicola Lama | |
Rolf Weitkunat | |||
Christelle Haziza | |||
Frank Lüdicke | |||
Gizelle Baker | |||
Patrick Picavet | |||
Valerie Poux | |||
P2860 | cites work | Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland. | Q50504186 |
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-Day randomized clinical trial of a menthol cigarette in Japan. | Q51312965 | ||
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: Eight-day randomized clinical trial in Korea. | Q51312968 | ||
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-Day randomized clinical trial in Japan. | Q51313800 | ||
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: Eight-day randomized clinical trial in the UK. | Q51313803 | ||
Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. | Q51759214 | ||
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. | Q53490047 | ||
Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2 | Q73457793 | ||
[Significance of urinary concentrations of S-benzyl-N-acetylcysteine (S-BMA) in subjects exposed to toluene] | Q73690715 | ||
A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product | Q86739758 | ||
Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting | Q87857545 | ||
Switching between menthol and nonmenthol cigarettes: findings from the U.S. Cohort of the International Tobacco Control Four Country Survey | Q34285832 | ||
Urine mutagenicity as an indicator of exposure to dietary mutagens formed during cooking of foods | Q34659796 | ||
Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 1. Study design and methodology | Q36482338 | ||
Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure | Q36482371 | ||
An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes. | Q36498669 | ||
Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke | Q36594351 | ||
Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes | Q36783343 | ||
Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population | Q36807462 | ||
The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US | Q37024750 | ||
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms | Q37157901 | ||
Reduced Exposure to Harmful and Potentially Harmful Smoke Constituents With the Tobacco Heating System 2.1. | Q37585216 | ||
Aerosol from a candidate modified risk tobacco product has reduced effects on chemotaxis and transendothelial migration compared to combustion of conventional cigarettes | Q38830586 | ||
Effects of cigarette smoke, cessation and switching to a candidate modified risk tobacco product on the liver in Apoe -/- mice--a systems toxicology analysis | Q39878597 | ||
In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette. | Q40228525 | ||
Validity of new biomarkers of internal dose for use in the biological monitoring of occupational and environmental exposure to low concentrations of benzene and toluene. | Q43261098 | ||
Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes | Q43638190 | ||
Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior | Q44877898 | ||
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking | Q45004311 | ||
Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking | Q45221728 | ||
The place for harm reduction and product regulation in UK tobacco control policy | Q46183052 | ||
Fast determination of urinary S-phenylmercapturic acid (S-PMA) and S-benzylmercapturic acid (S-BMA) by column-switching liquid chromatography-tandem mass spectrometry | Q46765779 | ||
Mutagenic activity of overnight urine from healthy non-smoking subjects. | Q50073692 | ||
A simple modification of the Salmonella liquid-incubation assay Increased sensitivity for detecting mutagens in human urine | Q50211268 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | L-menthol | Q407418 |
biomarker | Q864574 | ||
cigarette smoking | Q67433631 | ||
P304 | page(s) | 161-172 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
P1476 | title | Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings ( | |
P478 | volume | 20 |